These biogenic effects were replicated in vivo, where a GLP-1R/GIPR dual agonist normalized the quantities and volume of neuronal mitochondria in the brains of 3 × Tg (APP/PS1/Tau) AD mice (Cai et al., 2021). Here, PSEN1 is linked to Alzheimer disease.